Elcelyx Therapeutics, Inc. — Form D/A

Elcelyx Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2012-12-20. The offering totals $21.1M, of which $21.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (42)

Showing 25 of 42 people.

NameRoleLocation
Ralph E ChristoffersenDirectorLouisville, CO
Richard BarryDirectorOklahoma City, OK
Bosun HauDirectorSt. Louis, MO
Alain BaronDirectorSan Diego, CA
Alain BaronExecutive OfficerSan Diego, CA
Martin R BrownExecutive OfficerChambersburg, PA
RICHARD J BARRYDirectorCAMBRIDGE, MA
Ginger GrahamDirectorSan Diego, CA
Jim GlasheenDirectorSan Diego, CA
Mark FinemanExecutive OfficerSan Deigo, CA
Christoffersen RalphDirectorSan Diego, CA
Sandy MahatmeDirectorSan Diego, CA
Liang TsuiDirectorSan Diego, CA
Jay SherwoodExecutive OfficerSan Diego, CA
Ralph E ChristoffersonDirectorSan Diego, CA
Liang R TsuiDirectorSan Diego, CA
Alain D BaronDirectorSan Diego, CA
Alain D BaronExecutive OfficerSan Diego, CA
Ginger E GrahamDirectorSan Diego, CA
Mark R FinemanExecutive OfficerSan Diego, CA
Jim E GlasheenDirectorSan Diego, CA
Brook J ByersDirectorSan Diego, CA
Mark R WigginsExecutive OfficerSan Diego, CA
Ralph E ChristoffersenExecutive OfficerLouisville, CO
BROOK E BYERSDirectorSAN DIEGO, CA

Other filings by this issuer (9)

FiledFormOfferingSold
2018-11-07D$1.0M$476K
2015-10-07D$40.2M$20.1M
2015-02-19D$9.0M$5.8M
2014-02-21D/A$24.7M$24.7M
2013-02-26D$20.0M$12.0M
2012-08-13D/A$18.1M$18.1M
2011-05-10D/A$14.1M$14.1M
2011-01-26D$6.1M
2010-03-17D$2.2M$1.2M

More